WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Royal Peptides LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Rocco Abate and Michael Fraunfelter, Managers, Royal Peptides LLC, 2310 SE 2nd St. Ste 7, Boynton Beach, FL 33435, United States, admin@royal-peptides.com, info@royal-peptides.com

Issuing Office: Center for Drug Evaluation and Researc . . .

Click here for more information about our products